Risk factors for relapse among methamphetamine users receiving a joint legal –medical treatment program as a diversion intervention: A one-year follow-up study

Methamphetamine (METH) is a Schedule II illicit drug in Taiwan. A 12-month legal –medical joint intervention program has been developed for first-time METH offenders during deferred prosecution. Risk factors associated with METH relapse use among these individuals were unknown.
Source: Journal of Substance Abuse Treatment - Category: Addiction Authors: Source Type: research